Ingo Schmidt‐Wolf

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

Helmut Oettle, Stefan Post, P. Neuhaus et al. · JAMA · 2007 · 2.4K citations

Medicine, Oncology, Surgery +13

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

Pieter Sonneveld, Ingo Schmidt‐Wolf, Bronno van der Holt et al. · Journal of Clinical Oncology · 2012 · 826 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

Kai Neben, Henk M. Lokhorst, Anna Jauch et al. · Blood · 2011 · 357 citations

Medicine, Hematology, Pharmacotherapy +15

Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma

Ingo Schmidt‐Wolf, Sebastian Finke, Beate Trojaneck et al. · British Journal of Cancer · 1999 · 219 citations · Full text

Life Sciences, Immunology, Oncology +17

Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV

Susanne Saußele, Marie-Paloma Krauß, Rüdiger Hehlmann et al. · Blood · 2015 · 200 citations · Full text

Medicine, Hematology, Oncology +12